Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of Hypertension
NCT00000484Phase 3Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Apr 1966
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of chlorothiazide, rauwolfia in essential hypertension, sponsored by National Heart, Lung, and Blood Institute. Started Apr 1966; status: completed.
02
Drugs
chlorothiaziderauwolfia
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00000484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000484.